In vitro immunotoxicological assays for detection of compounds requiring metabolic activation. by Tucker, A N et al.
Environmental Health Perspectives
Vol. 43, pp. 123-127, 1982
In Vitro Immunotoxicological Assays for
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Metabolic Activation
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Hallett,*Bernadine M. Kauffmann*and Albert E. Munson*
A system formetabolic activation ofcyclophosphamide (CP), consisting ofa crude microsomal
fraction of mouse liver and necessary cofactors (S9 mix), was interfaced with three murine cell
culture assays for immunotoxicity. These assays were: the Mishell-Dutton assay for in vitro
antibody formation, splenic lymphocyte responsiveness to mitogens and bone marrow cell
cultures. There was no effect of CP at doses up to 261 ,ug/ml (1mM) on any of the parameters
measured unless S9 mix was included. Much greater potency was achieved if the S9 mix was
prepared from livers of mice pretreated with phenobarbital. Under these conditions a dose-
related inhibition of plaque-forming cells (PFC) in the Mishell-Dutton assay was observed,
yielding an ED50 of6.3 ,ug/ml. When splenic lymphocytes were exposed to CP in the presence of
induced S9 mix, a dose related inhibition of the response to the B-cell mitogen, lipopolysaccha-
ride (LPS), and to the T-cell mitogen, concanavalin A (Con A), was observed. For the optimum
LPS concentration, the ED50 for CP was 8.1 ,ug/ml; for the optimum concentration ofCon A, the
ED50 was 6.7 ,ug/ml. DNA synthesis was not inhibited by the doses used. When bone marrow cells
were exposed to CP in the presence of induced S9 mix, the stem cell population, enumerated by
colonization in semisolid medium, was reduced in a dose-dependent manner, with an ED5 of5.2
,ug/ml. Again, DNA synthesis was not affected unless higher doses of CP were used.
In vitro assays for defining toxicological effects
are becoming increasingly important as the burden
ofnecessaryinvestigationsincreases. Ourlaboratory
has successfully interfaced a system for metabolic
activation with several in vitro assays for immuno-
toxicity, thus widening the scope ofthese assays to
include immunosuppressive agents which are not
direct acting. Cyclophosphamide (CP) was chosen
as apositive control in these assays since it requires
metabolic activation (1) and is immunosuppressive
in the mouse (2).
Metabolic Activation System
A crude microsomal fraction was prepared from
livers of male BALB/c mice to serve as a source of
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enzymes for metabolic activation. In some cases,
the enzymes were induced with phenobarbital by
placing 1 mg/ml in the animals' drinkingwater for 1
week until 24 hr prior to sacrifice by cervical dislo-
cation. Livers were removed aseptically and homog-
enized in 3 mlofcold, sterile 1.15% KCl/gliver. This
homogenate was centrifuged at 9000g and the
supernatant (S9 fraction) removed and frozen in 1
ml aliquots. When used, a tube of S9 was removed
from storage at -70°C, thawed and added to a
solution ofcofactors. This S9 mix contained 3 mg S9
protein, 2 mM NADP, and 35 mM isocitrate in
sterile culture medium and was added directly to
cell suspensions, 0.1 ml/ml of cell suspension.
Mishell-Dutton Assay
The Mishell-Dutton in vitro antibody-producing
assay has been found useful for recognizing immu-
123Table 1. In vitro inhibition ofthe primary antibody response to sheep erythrocytes by cyclophosphamide in the Mishell-Dutton
assay.a
Cyclophosphamide
mM ,ug/ml S9 Mix PFC/culture 106 Cells PFC/106 cells
None 0 None 1760 ± 210 5.55 ± 0.47 317
1.0 261 None 1707 ± 154 5.27 ± 0.17 324
None 0 Naive 2520 ± 218 5.00 ± 0.23 504
0.1 26 Naive 1807 ± 140 4.12 ± 0.59 439
0.3 78 Naive 1035 ± 121 5.02 ± 0.81 206
1.0 261 Naive 727 ± 144 2.92 ± 0.34 249
None 0 Induced 2227 ± 154 5.05 ± 0.41 441
0.01 2.6 Induced 1835 ± 161 3.62 ± 0.53 507
0.03 7.8 Induced 795 ± 111 3.65 ± 0.18 218
0.10 26 Induced None 1.88 ± 0.23 0
aSpleens were obtained from male BALB/c mice, 10 weeks ofage. Plaque forming cells (PFC) were enumerated on day 5 ofculture
and are expressed as the mean ± standard error (n = 3). Background (no antigen) was 102 ± 23 PFC/culture.
nosuppressive chemicals(3). Inadditiontospecificity,
the system offers the advantage ofcomplex cellular
interactionsinvolvedtoachievetheultimateresponse.
The disadvantage of the assay, as pointed out by
Kutz et al. (4), is that chemicals which require
activation to reactive metabolites are not detecta-
ble. With the modification described here, chemi-
calswhichrequire metabolicactivationcanbetested
in the assay.
The modified assay was carried out by first pre-
paring a spleen cell suspension in RPMI 1640 cul-
ture medium and adjusting the cell concentration to
1.5 x 107 cells/ml. The suspension was then distri-
buted into 10 x 35 mmplastic petri plates, 1 ml per
plate. To each plate was added 0.1 ml ofS9 mix and
CP (Sigma) as indicated in Table 1. The plates were
incubated at 37°C for 1 hr in a culture box gassed
with a mixture of 10% Co2, 7%02, 83% N2 on a
rocker platform.
As described elsewhere (5), the 1 hr preincuba-
tion was necessary because of loss of response of
the assay when S9 mix was added at the time of
antigen and left in for the 5 days ofculture. Follow-
ing this incubation period, the contents of each
plate were transfered to a sterile plastic tube and
centrifuged at 2000g for 10 min. Each pellet was re-
suspended in 1 ml RPMI 1640 (1 x 107 cells/ml),
0.1 ml fetal calf serum and antigen (5 x 106 sheep
erythrocytes) were added, and 1 ml ofthe resulting
suspension was placed in a fresh petri plate. The
plates were then placed in the culture boxes, gassed
with the special mixture, and incubated at 37°C
with gentle rocking and daily feeding as described
by Mishell and Dutton (6). On day5, the contents of
each plate were collected for enumeration ofplaque-
forming cells (PFC) using Cunningham slides (7).
Cell counts were performed by using a Model ZBI
Coulter counter.
TheeffectofCP ontheprimaryantibodyresponse
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ofsplenic lymphocytes to sheep erythrocytes using
the modified Mishell-Dutton assayis showninTable
1. The control value (1760 PFC/culture) can be
compared to a mean control value from six experi-
ments not involving the modification of2680 + 273.
Cyclophosphamide had no effect up to lmM (261
,g/ml) when S9 mixwas notincluded, but produced
a dose-dependent inhibition in the presence of S9
from livers ofeithernaive orphenobarbital-induced
mice. The use of the induced preparation caused a
tenfold increase in potency of CP, as would be
expected. The preparations used in this experiment
had been stored for 3 months at -70°C. Although
the fractions were more active when used shortly
after preparation, the induced preparation was
slightly inhibitory at that time.
There is an effect on cell yield at the higher doses
of CP when S9 mix is included which seems to be
related to the reduced yield of PFC/culture. For
comparison, PFC/106 cells is shown in the last col-
umn of Table 1. Approximate ED50 values for CP
when activated by induced S9 are 6.3 ,ug/ml with
PFC/cultureasendpointand7.8 ,ug/mlwithPFC/106
cells as endpoint.
Splenic Lymphocyte Cultures
We have been using murine splenic lymphocyte
cultures to assess immunotoxicity of a variety of
chemicals. Theparametersmeasuredincludeeffects
on DNA synthesis and response ofthe lymphocytes
to mitogens. The use ofthe S9 mix and effect ofCP
in this assay will be described.
Cell suspensions were prepared in RPMI 1640 by
using spleens from male CD-1 mice, a random-bred
albino from Charles River, which were 10-12 weeks
of age. This strain is also being used in our labora-
tory for in vivo toxicological studies. Following
collection of the cells by centrifugation, the pellet
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FIGURE 1. Effect ofcyclophosphamide on cultured murine splenic lymphocytes. Suspensions oflymphocytes were exposed for 1 hrto
cyclophosphamide at the doses indicated. In some cases S9 mix from either naive or phenobarbital induced mouse livers was
included, as indicated by hatched or solid bars, respectively. The values shown are means from triplicate exposures.
was resuspended in RPMI 1640 containing 10% calf
serum and adjusted to 5 x 106 cells/ml. Cyclophos-
phamide and S9 mix were added to triplicate sili-
conized glass tubes, each containing 5 ml ofcells. A
1-hr incubation was performed with the tubes in a
roller drum in a 37°C, 5% CO2 incubator. At the
end of this incubation, the cells were collected by
centrifugation and resuspended in RPMI 1640 con-
taining 10% fetal calf serum for counting. Viability
was determined by trypan blue exclusion.
For determination ofDNAsynthesis, aportion of
the cell suspension was adjusted to 3 x 106 cells/ml
and incorporation of 1251-iododeoxyuridine (IUdR)
was measured in the presence of 1 ,uM fluorode-
oxyuridine (FUdR). In this assay, 6replicate 200 p.l
aliquots were incubated with label in a microtiter
plate for 1 hr, and the cells were collected with a
Titertek Cell Harvester. Quantitation of125I wasby
gamma counter.
The response ofsplenic lymphocytes to the B-cell
mitogen, lipopolysaccharide (LPS) from Salmonel-
la, and the T-cell mitogen, concanavalin A (Con A),
was determined by IUdR incorporation also. Sus-
pensions were adjusted to 5 x 106 cells/ml and six
100 pul replicatesincubatedwithmitogeninmicrotiter
plates in a 37°C, 10% CO2 incubator for 48 hr.
Three concentrations of each mitogen were used.
Thesamples werethenpulsedfor 18hrwith1"IUdR/
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Table 2. DNA synthesis in spleen cells exposed to cyclo-
phosphamide in the presence of S9 mixes.
125IUdR incorporation, cpm/6 x 105 cellsa
CP, Without Naive Induced
,ug/ml S9 Mix S9 Mix S9 Mix
0 4093 + 128 4109 ± 90 4089 ± 273
1.6 ND ND 3791 ± 256
3.25 ND ND 3897 ± 75
6.5 ND 3515 ± 236 4026 ± 200
13 ND 3460 ± 194 4020 ± 201
26 ND 3742 ± 203 3160 ± 76
52 ND 3680 ± 101 ND
104 3607 ± 600 4045 ± 214 ND
aMeans ± standard error (n = 3); ND = not done.
FUdR and the 125I incorporation determined as
described for DNA synthesis.
Cell recovery was not affected by CP, even when
S9 mix was included. This is illustrated graphically
in Figure 1. Viability, which was 91% in the control
was also not changed by any of the treatments.
DNA synthesis was also unaffected, as shown in
Table 2 and Figure 1. Data from other experiments
which are not shown here indicate that CP in the
presence of induced S9 inhibits DNA synthesis at
higherdosesthanusedintheexperimentdescribed.
Mitogenicity data are shown in Table 3 and Fig-
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STable 3. Spleen cell response to mitogens in the presence of cyclophosphamide (CP) or S9.
'25IUdR incorporation, 103 cpm/5 x 105 cellsa
Without S9, Without S9, Naive S9, Induced S9,
Mitogen no CP CP = 104 ,ug/ml no CP no CP
LPS
1 ,ug/well 63.7 ± 3.3 69.8 ± 2.9 73.3 ± 0.3 67.7 ± 3.4
5 ,ug/well 66.0 ± 3.6 68.9 ± 0.8 85.2 ± 7.8 67.4 ± 3.9
20 p.g/well 60.3 ± 4.3 61.0 ± 1.8 63.7 ± 2.9 58.9 ± 3.0
Con A
1 ,ug/well 155.9 ± 5.4 161.1 ± 2.6 173.1 ± 2.2 138.3 ± 5.8
5 ,ug/well 188.4 ± 2.7 188.4 ± 2.7 198.8 ± 4.9 181.0 ± 6.6
10 ,ug/well 55.4 ± 3.2 51.1 ± 3.8 51.1 ± 3.2 27.7 ± 10.8
None 1.5 ± 0.2 1.9 ± 0.2 1.7 ± 0.1 2.1 ± 0.2
aMean ± standard error (n = 3).
ure 1. Table 3 gives the control values, and Figure 1
is a graphic representation of mitogen responsive-
ness when both CP and S9 are included in the 1-hr
preincubation. A dose-dependent inhibition by CP
is observed when S9 is included, and this inhibition
occurs at lower doses if S9 from phenobarbital
induced animals is used as the source of activating
enzymes. The ED50in this case is 8.1 ,ug/ml for LPS
(5 ,ug/well) and 6.7 ,ug/ml for Con A (5 ,ug/well).
Bone Marrow Cultures
Immediately after removal of spleens from CD-1
mice, the hind limbs were removed and placed on
ice. Using aseptic techniques, the femurs were
trimmed and the contents flushed into a plastic
centrifuge tube with a MEM (minimum essential
medium)containing 10%fetalcalfserumandadjusted
to 3 x 106 cells/ml. Aliquots of5 ml were placed in
siliconized glass tubes, S9 mix and CP added where
indicated, and the tubes incubated 1 hr in the roller
drum as described for splenic lymphocytes. Cells
were then collected by centrifugation and resus-
pended in a MEM with 10% fetal calf serum. Cell
concentration and viability were determined, then
the cells were adjusted to 3 x 106 cells/ml for
determination of DNA synthesis as described for
lymphocytes.
Viable stem cells were then enumerated by colo-
nization in semisolid medium. For this determina-
tion, the cells were adjusted to 105 cells/ml in a
MEM-containing 10% fetal calf serum, 5% horse
serum, 1.8% methyl cellulose, and 10% L-cell condi-
tioned medium. A 2-ml portion of suspension was
placed in each of three wells in a six-well Linbro
plate, and the plates incubated at 37°C, 10% C02,
95% humidity for 7-10 days. Colonies, defined as
clusters of 25 cells or more, were then counted.
The results of atypical dose response experiment
using S9 fromboth naive and phenobarbitalinduced
animals are given in Table 4. Cell yield was not
affected by the treatment; viability was 91-93% in
controls as well as all high dose samples. As shown
in Table 4, there was no inhibition ofDNA synthe-
sis at any dose of CP, even when S9 was included.
Colony formation was affected; however, in a dose
related manner when S9 from either naive animals
or phenobarbital induced animals was included.
Approximate ED50 values for the CP effect on stem
cells are 20.8 ,ug/ml for uninduced S9 and 5.2 ,ug/ml
for induced S9.
Discussion
In vitro activation of CP was first described in
Ames' Salmonella microsome test for mutagenicity
Table 4. Effect of cyclophosphamide on DNA synthesis and stem cells in bone marrow cell cultures.a
DNA Synthesis, 103 cpm 125I Stem cell enumeration, colonies/105 cells
CP, ,ug/ml Without S9 Naive S9 Induced S9 Without S9 Naive S9 Induced S9
None 33.5 ± 4.0 24.6 ± 3.1 23.2 ± 0.9 163.4 ± 1.0 163.4 ± 0.9 161.1 ± 0.9
3.25 ND ND 27.0 ± 2.2 ND ND 104.1 ± 0.7
6.5 ND 24.3 ± 1.3 31.3 ± 2.0 ND 142.4 ± 1.0 66.9 ± 1.5
13 ND 25.7 ± 1.1 33.2 ± 2.5 ND 123.7 ± 1.5 29.3 ± 2.2
26 40.6 ± 3.9 33.7 ± 2.1 ND 162.7 ± 2.2 51.6 ± 2.0 ND
"All values represent the mean ± standard error (n = 3). ND = not done.
Environmental Health Perspectives 126Table 5. Summary of ED50 values for cyclophosphamide
activated in vitro by S9 mix from phenobarbital-induced
mice.a
Assay End point ED50, ,ug/ml
Mishell-Dutton PFC/culture 6.3
PFC/106 cells 7.8
Spleen lymphocyte Response to LPS 8.1
(5 ,ug/well)
Response to Con A 6.7
(5 ,ug/well
DNA synthesis >26
Bone marrow Stem cell 5.2
DNA synthesis >26
RThe values shown here were obtained from log dose plots of
data shown in the other tables.
(8). Since then, it has been used as a model com-
pound in other, more sophisticated mammalian in
vitro assays. Stetka and Wolff were able to induce
sisterchromatid exchangesinculturedChinese ham-
ster ovary cells by including rat liver microsomes
with CP (9). Recently, an in vitro teratogenic assay
was described in which CP induced defects when an
hepatic microsomal fraction was included (10). The
present report extends use ofin vitro activation of
CP into the area of immunotoxicology.
A system for metabolic activation of CP in vitro
has been successfully interfaced with three cell
culture assays for immunotoxicity. A summary of
the effects ofCP when activated by an S9 mix from
phenobarbital induced animals is given in Table 5.
The approximate ED50 values forspecific endpoints
in the three assays are very similar, ranging from
5.2 to 8.1 p,g/ml or 2.0 to 3.1 x 1OM. It is impor-
tant to note that DNA synthesis is inhibited only
when much higher doses ofCP are used. The utility
of the described assays is tremendously increased
by inclusion ofthe S9 mix, in that they can now be
used for screening for immunotoxicity, as well as
elucidation of mechanisms of action. As with all in
vitro assays, it is important to keep the information
in context with in vivo effects.
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